Trevi Therapeutics Inc (TRVI)
4.50 x 3 7.00 x 3
Pre-market by (Cboe BZX)
6.31 -0.28 (-4.25%) 04/29/25 [NASDAQ]
4.50 x 3 7.00 x 3
Pre-market 6.31 unch (unch) 16:00 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | TRVI | ABUS | ARVN | ||
| Company | Trevi Therapeutics Inc | Arbutus Biopharma Corp | Arvinas Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 6.54 | 3.34 | 9.31 | ||
| High | 6.74 | 3.45 | 9.55 | ||
| Low | 6.28 | 3.33 | 9.11 | ||
| Last | 6.31 | 3.41 | 9.37 | ||
| Change | -0.28 | +0.07 | +0.16 | ||
| % Change | -4.25% | +2.10% | +1.74% | ||
| Volume | 3,809,600 | 950,000 | 1,700,700 | ||
| 20-Day Average Volume | 1,576,295 | 1,170,345 | 2,425,485 | ||
| Previous Close | 6.59 | 3.34 | 9.21 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.01 | 3.24 | 7.76 | ||
| 20-Day Raw Stochastic | 77.25% | 78.02% | 95.03% | ||
| 20-Day Relative Strength | 56.88% | 54.28% | 47.10% | ||
| Weighted Alpha | +33.59 | +15.75 | -48.69 | ||
| Today's Opinion | 100% Buy | 48% Sell | 88% Sell | ||
| Previous Opinion | 100% Buy | 56% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 48% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.95% since 04/22/25 | +6.90% since 04/22/25 | +4.81% since 04/22/25 | ||
| Low | 6.01 on 04/23/25 | 3.22 on 04/23/25 | 8.83 on 04/23/25 | ||
| High | 6.74 on 04/29/25 | 3.45 on 04/29/25 | 9.55 on 04/29/25 | ||
| 1-Month | |||||
| %Chg | -2.92% since 03/28/25 | -2.57% since 03/28/25 | +23.45% since 03/28/25 | ||
| Low | 4.85 on 04/10/25 | 2.70 on 04/09/25 | 5.93 on 04/09/25 | ||
| High | 6.74 on 04/29/25 | 3.61 on 04/02/25 | 9.55 on 04/29/25 | ||
| 3-Month | |||||
| %Chg | +63.47% since 01/29/25 | +0.89% since 01/29/25 | -46.61% since 01/29/25 | ||
| Low | 3.77 on 02/12/25 | 2.70 on 04/09/25 | 5.93 on 04/09/25 | ||
| High | 7.39 on 03/10/25 | 3.70 on 02/25/25 | 20.38 on 02/18/25 | ||
| 6-Month | |||||
| %Chg | +104.87% since 10/29/24 | -15.59% since 10/29/24 | -65.93% since 10/29/24 | ||
| Low | 2.36 on 12/11/24 | 2.70 on 04/09/25 | 5.93 on 04/09/25 | ||
| High | 7.39 on 03/10/25 | 4.03 on 10/30/24 | 29.61 on 10/30/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 637,134 | 639,543 | 633,390 | ||
| Shares Outstanding, K | 96,682 | 191,480 | 68,772 | ||
| Annual Sales | 0 | 6,170,000 | 263,400,000 | ||
| Annual Net Income | -47,910,000 | -69,920,000 | -198,900,000 | ||
| Last Quarter Sales | 0 | 1,570,000 | 59,200,000 | ||
| Last Quarter Net Income | -11,420,000 | -12,530,000 | -45,100,000 | ||
| 60-Month Beta | 0.41 | 1.45 | 2.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 03/18/25 | -0.07 on 03/27/25 | -0.63 on 02/11/25 | ||
| Latest Earnings Date | 05/06/25 | 05/01/25 | 05/01/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||